For how many months can steroid withdrawal symptoms persist?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Steroid Withdrawal Symptoms Duration

Steroid withdrawal symptoms typically last 6-10 months, though the duration varies significantly based on the dose, duration of therapy, and individual patient factors. 1, 2

Evidence-Based Timeline

The most authoritative guidance comes from the 2024 European Society of Endocrinology/Endocrine Society joint clinical guideline, which emphasizes that glucocorticoid withdrawal syndrome is a recognized clinical entity affecting up to 50% of patients during steroid taper 1. While the guideline doesn't specify an exact duration, research data provides clearer timeframes:

  • Median duration: 10 months (range 6-10 months) in patients following surgical treatment for endogenous Cushing's syndrome 2
  • Symptoms typically worsen when the total daily glucocorticoid dose reaches below 30-35 mg hydrocortisone equivalent (approximately 7.5 mg prednisone) 1

Clinical Presentation

Withdrawal symptoms include:

  • Myalgias and muscular weakness
  • Fatigue (present in 60% of symptomatic patients)
  • Arthralgias (60%)
  • Sleep disturbances
  • Mood changes
  • Loss of appetite (20%)
  • Hypotension (15%)
  • Headaches (5%)

1, 3

Key Factors Affecting Duration

Longer symptom duration occurs with:

  • Higher glucocorticoid doses during treatment
  • Longer duration of therapy (>2 years significantly increases risk) 3
  • Long-acting glucocorticoids (dexamethasone, betamethasone)
  • Presence of exogenous Cushing syndrome features
  • Higher clinical severity scores at baseline 1

Critical Distinction: Withdrawal vs. Adrenal Insufficiency

A common pitfall is confusing glucocorticoid withdrawal syndrome with true adrenal insufficiency. The guideline provides practical guidance: consider the total daily glucocorticoid dose. For example, a patient on prednisone 20-40 mg may experience withdrawal symptoms, but true adrenal insufficiency concerns only arise once the taper reaches 5-7.5 mg 1. This is because withdrawal symptoms can occur even with acceptable cortisol levels due to glucocorticoid tolerance mechanisms involving inflammatory cytokines, particularly interleukin-6 2.

Management Strategy

The only proven intervention to prevent severe withdrawal symptoms is slow dose reduction 1. When severe withdrawal syndrome occurs despite gradual tapering:

  1. Temporarily increase the glucocorticoid dose back to the most recent tolerated level
  2. Extend the duration of the taper schedule
  3. Switch from long-acting to short-acting agents (e.g., from dexamethasone to prednisone or hydrocortisone) 1

The syndrome is self-limiting and responds well to temporary dose increases 2. Patients with higher clinical severity scores (based on physical features and comorbidities from glucocorticoid excess) require slower tapers, while those with lower scores can tolerate more rapid reduction 1.

Special Considerations

For topical steroid withdrawal (a distinct entity), symptoms can persist for 18 months to 4 years in pediatric cases, though most patients ultimately improve 4. This represents a different pathophysiology than systemic glucocorticoid withdrawal.

Bottom line: Plan for a 6-10 month recovery period when tapering chronic systemic glucocorticoids, adjust the taper speed based on symptom severity, and distinguish withdrawal symptoms from true adrenal insufficiency based on the current glucocorticoid dose.

References

Research

Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004

Research

Topical Steroid Withdrawal: A Case Series of 10 Children.

Acta dermato-venereologica, 2019

Related Questions

What withdrawal symptoms may occur when stopping prednisone and what is the recommended tapering schedule?
Can steroid withdrawal occur after stopping 2% hydrocortisone topical cream?
What is the appropriate management plan for a 58-year-old female with a 17-year history of chronic cough after pneumonia, intermittent sputum production, dyspnea on exertion, nicotine dependence with a 48 pack‑year smoking history (currently smoking ~1 pack every two weeks), who is not on inhalers and requires smoking cessation therapy, a short‑acting bronchodilator inhaler, a 14‑day course of nebulized ipratropium bromide, a cough suppressant, a chest radiograph, and glucose monitoring before a corticosteroid injection?
In a patient already on BiPAP with 3 L oxygen who is experiencing increased lethargy, what corticosteroid regimen is recommended?
In an adult with an acute cough from a viral or uncomplicated bacterial respiratory infection, what is the recommended treatment and how do dexamethasone and prednisone compare for short‑course corticosteroid therapy?
Summarize the types of diabetes mellitus and the workup required for each type.
How should I manage a first unprovoked seizure lasting one minute in a 62-year-old man?
Should metformin be initiated in a 63-year-old patient with an HbA1c of 7%?
What is the efficacy and what precautions should be considered for early accelerated rehabilitation in the conservative (non‑surgical) management of a fresh Achilles tendon rupture?
What is the recommended management for a patient with severe pulmonary arterial hypertension?
In a female patient with an ESBL‑producing urinary tract infection who has completed a 5‑day course of Zerbaxa (ceftazidime/avibactam), should a single dose of fosfomycin be given and used as prophylaxis upon discharge?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.